pubmed-article:18620382 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18620382 | lifeskim:mentions | umls-concept:C0148199 | lld:lifeskim |
pubmed-article:18620382 | lifeskim:mentions | umls-concept:C1831796 | lld:lifeskim |
pubmed-article:18620382 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:18620382 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:18620382 | lifeskim:mentions | umls-concept:C1880355 | lld:lifeskim |
pubmed-article:18620382 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:18620382 | pubmed:issue | 15 | lld:pubmed |
pubmed-article:18620382 | pubmed:dateCreated | 2008-8-7 | lld:pubmed |
pubmed-article:18620382 | pubmed:abstractText | Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway has emerged as one of the most promising new approaches for cancer therapy. We describe herein the key steps starting from an initial screening hit leading to the discovery of pazopanib, N(4)-(2,3-dimethyl-2H-indazol-6-yl)-N(4)-methyl-N(2)-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine, a potent pan-VEGF receptor (VEGFR) inhibitor under clinical development for renal-cell cancer and other solid tumors. | lld:pubmed |
pubmed-article:18620382 | pubmed:language | eng | lld:pubmed |
pubmed-article:18620382 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620382 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18620382 | pubmed:month | Aug | lld:pubmed |
pubmed-article:18620382 | pubmed:issn | 1520-4804 | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:KumarRakeshR | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:NolteRobert... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:WangLipingL | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:StaffordJeffr... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:HarrisPhilip... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:KnickVictoria... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:VealJames MJM | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:AlfanoNoraN | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:SzewczykJerzy... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:CheungMuiM | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:JohnsonJennif... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:HunterRobert... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:LuttrellDeird... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:TruesdaleAnne... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:Davis-WardRon... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:CrosbyRenae... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:EpperlyAndrea... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:RudolphSharon... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:HinkleKevin... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:LaudemanChris... | lld:pubmed |
pubmed-article:18620382 | pubmed:author | pubmed-author:MookRobert... | lld:pubmed |
pubmed-article:18620382 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18620382 | pubmed:day | 14 | lld:pubmed |
pubmed-article:18620382 | pubmed:volume | 51 | lld:pubmed |
pubmed-article:18620382 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18620382 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18620382 | pubmed:pagination | 4632-40 | lld:pubmed |
pubmed-article:18620382 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:meshHeading | pubmed-meshheading:18620382... | lld:pubmed |
pubmed-article:18620382 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18620382 | pubmed:articleTitle | Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. | lld:pubmed |
pubmed-article:18620382 | pubmed:affiliation | GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709, USA. philip.a.harris@gsk.com | lld:pubmed |
pubmed-article:18620382 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:18620382 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620382 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620382 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620382 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620382 | lld:pubmed |